Cargando…
The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
Background. The aim of this study was to validate the impact of type 2 diabetes (T2D) on the platelet reactivity in patients with acute ST elevation myocardial infarction (STEMI) treated with adenosine diphosphate (ADP) receptor blockers. Methods. A pilot prospective study was performed. Totally 67...
Autores principales: | Samoš, Matej, Fedor, Marián, Kovář, František, Galajda, Peter, Bolek, Tomáš, Stančiaková, Lucia, Fedorová, Jana, Staško, Ján, Kubisz, Peter, Mokáň, Marián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967473/ https://www.ncbi.nlm.nih.gov/pubmed/27493970 http://dx.doi.org/10.1155/2016/2909436 |
Ejemplares similares
-
Type 2 Diabetes and ADP Receptor Blocker Therapy
por: Samoš, Matej, et al.
Publicado: (2016) -
Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017) -
Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
por: Samoš, Matej, et al.
Publicado: (2021) -
Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
por: Škorňová, Ingrid, et al.
Publicado: (2021) -
Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013)